Estimating heterogeneous treatment effects for latent subgroups in observational studies

Individuals may vary in their responses to treatment, and identification of subgroups differentially affected by a treatment is an important issue in medical research. The risk of misleading subgroup analyses has become well known, and some exploratory analyses can be helpful in clarifying how covariates potentially interact with the treatment. Motivated by a real data study of pediatric kidney transplant, we consider a semiparametric Bayesian latent model and examine its utility for an exploratory subgroup effect analysis using secondary data. The proposed method is concerned with a clinical setting where the number of subgroups is much smaller than that of potential predictors and subgroups are only latently associated with observed covariates. The semiparametric model is flexible in capturing the latent structure driven by data rather than dictated by parametric modeling assumptions. Since it is difficult to correctly specify the conditional relationship between the response and a large number of confounders in modeling, we use propensity score matching to improve the model robustness by balancing the covariates distribution. Simulation studies show that the proposed analysis can find the latent subgrouping structure and, with propensity score matching adjustment, yield robust estimates even when the outcome model is misspecified. In the real data analysis, the proposed analysis reports significant subgroup effects on steroid avoidance in kidney transplant patients, whereas standard proportional hazards regression analysis does not.

[1]  Paul R. Rosenbaum,et al.  Comparison of Multivariate Matching Methods: Structures, Distances, and Algorithms , 1993 .

[2]  J. M. Taylor,et al.  Subgroup identification from randomized clinical trial data , 2011, Statistics in medicine.

[3]  R. Grenda Minimizing steroid use in pediatric kidney recipients , 2011, Pediatric transplantation.

[4]  I. Lipkovich,et al.  Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials , 2017, Statistics in medicine.

[5]  R. Elashoff,et al.  A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial , 2011, Statistics in medicine.

[6]  B. Tönshoff,et al.  A Randomized Trial to Assess the Impact of Early Steroid Withdrawal on Growth in Pediatric Renal Transplantation: The TWIST Study , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  K. Johansen,et al.  Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs. , 2004, Journal of the American Society of Nephrology : JASN.

[8]  Jennifer L. Hill,et al.  Bayesian Nonparametric Modeling for Causal Inference , 2011 .

[9]  Xiaogang Su,et al.  Interaction Trees with Censored Survival Data , 2008, The international journal of biostatistics.

[10]  David M Kent,et al.  Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. , 2007, JAMA.

[11]  R. Chang,et al.  Growth and weight gain of prepubertal children after cardiac transplantation , 2008, Pediatric transplantation.

[12]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[13]  D. Rubin,et al.  Using Multivariate Matched Sampling and Regression Adjustment to Control Bias in Observational Studies , 1978 .

[14]  H. Chipman,et al.  BART: Bayesian Additive Regression Trees , 2008, 0806.3286.

[15]  A. Israni,et al.  A simple tool to predict outcomes after kidney transplant. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  B. Chavers,et al.  Pediatric Kidney Transplantation Using a Novel Protocol of Rapid (6-Day) Discontinuation of Prednisone: 2-Year Results , 2009, Transplantation.

[17]  D. Rubin Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco Litigation , 2001, Health Services and Outcomes Research Methodology.

[18]  P. Austin Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples , 2009, Statistics in medicine.

[19]  Bo Lu,et al.  Bias associated with using the estimated propensity score as a regression covariate , 2014, Statistics in medicine.

[20]  L. Goldstein,et al.  Prognostic and predictive factors in early-stage breast cancer. , 2004, The oncologist.

[21]  Stephanie T. Lanza,et al.  Latent Class Analysis: An Alternative Perspective on Subgroup Analysis in Prevention and Treatment , 2013, Prevention Science.

[22]  Lu Tian,et al.  A Simple Method for Detecting Interactions between a Treatment and a Large Number of Covariates , 2012, 1212.2995.

[23]  A. Italiano,et al.  Prognostic or predictive? It's time to get back to definitions! , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Mi-Ok Kim,et al.  Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance—a propensity score-matched study , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  N. Bundred,et al.  Prognostic and predictive factors in breast cancer. , 2001, Cancer treatment reviews.

[26]  Menggang Yu,et al.  Regularized outcome weighted subgroup identification for differential treatment effects , 2015, Biometrics.

[27]  J. Mahan,et al.  Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement , 2006, Pediatric Nephrology.

[28]  Xin Qun Wang,et al.  Racial disparities in renal transplant outcomes. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  J. Lunceford,et al.  Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study , 2004, Statistics in medicine.

[30]  Min Zhang,et al.  Estimating optimal treatment regimes from a classification perspective , 2012, Stat.

[31]  J. Goebel,et al.  Outcomes of Steroid‐Avoidance Protocols in Pediatric Kidney Transplant Recipients , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[32]  Gang Li,et al.  Latent Subgroup Analysis of a Randomized Clinical Trial through a Semiparametric Accelerated Failure Time Mixture Model , 2013, Biometrics.

[33]  W. Loh,et al.  A regression tree approach to identifying subgroups with differential treatment effects , 2014, Statistics in medicine.

[34]  Daniel F Hayes,et al.  Prognostic and predictive factors revisited. , 2005, Breast.

[35]  Bo Lu,et al.  Estimating the Effect of Premarital Cohabitation on Timing of Marital Disruption , 2012 .

[36]  D. Hooper,et al.  Clinical Practice of Steroid Avoidance in Pediatric Kidney Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[37]  D A Follmann,et al.  A Multivariate Test of Interaction for Use in Clinical Trials , 1999, Biometrics.

[38]  Helena Chmura Kraemer,et al.  Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach , 2013, Statistics in medicine.

[39]  P. Rothwell Subgroup analysis in randomised controlled trials: importance, indications, and interpretation , 2005, The Lancet.

[40]  Minnie M Sarwal,et al.  Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation1 , 2003, Transplantation.